Windtree Therapeutics Appoints New CEO

Seeking Alpha11/14 21:59

Windtree Announces Craig Fraser Plans To Retire From His Role As Chief Executive Officer, Effective December 1, 2024, Will Remain On The Board Of Directors Of The Company As Chairman; Board Has Appointed Jed Latkin, A Current Director Of The Company,...

Benzinga11/14 21:03

Windtree Therapeutics: Latkin Will Also Remain a Member of the Bd >WINT

Dow Jones11/14 21:02

Windtree Therapeutics: Fraser Will Remain on Board as Chairman

Dow Jones11/14 21:02

Windtree Therapeutics Initiates SEISMiC C Study Of Istaroxime In SCAI Stage C Cardiogenic Shock For Planned Completion Of Phase 2b And Transition To Phase 3

Benzinga10/30 20:16

Windtree Completes National Phase Filings Of Patent Applications In US, Germany, France, Italy, Japan And China

Benzinga10/23 20:13